BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang Y, Wang J, Jiang K, Chung EJ. Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions. J Control Release 2021;334:127-37. [PMID: 33892054 DOI: 10.1016/j.jconrel.2021.04.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Abdellatif AAH, Mohammed HA, Khan RA, Singh V, Bouazzaoui A, Yusuf M, Akhtar N, Khan M, Al-subaiyel A, Mohammed SAA, Al-omar MS. Nano-scale delivery: A comprehensive review of nano-structured devices, preparative techniques, site-specificity designs, biomedical applications, commercial products, and references to safety, cellular uptake, and organ toxicity. Nanotechnology Reviews 2021;10:1493-559. [DOI: 10.1515/ntrev-2021-0096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
2 Xiong Y, Wang Z, Wang Q, Deng Q, Chen J, Wei J, Yang X, Yang X, Li Z. Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy. Theranostics 2022;12:944-62. [PMID: 34976222 DOI: 10.7150/thno.67572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Shin H, Jeong S, Lee Y, Jeon C, Kwon G, Kim S, Lee D. H2O2-Activatable Antioxidant Polymeric Prodrug Nanoparticles for the Prevention of Renal Ischemia/Reperfusion Injury. Biomacromolecules 2022. [PMID: 35929737 DOI: 10.1021/acs.biomac.2c00669] [Reference Citation Analysis]
4 Merlin JPJ, Li X. Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases. Front Genet 2021;12:817974. [PMID: 35069707 DOI: 10.3389/fgene.2021.817974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Davis G, Kurse A, Agarwal A, Sheikh-hamad D, Kumar MNVR. Nano-encapsulation strategies to circumvent drug-induced kidney injury and targeted nanomedicines to treat kidney diseases. Current Opinion in Toxicology 2022. [DOI: 10.1016/j.cotox.2022.100346] [Reference Citation Analysis]
6 Kosanović M, Milutinovic B, Glamočlija S, Morlans IM, Ortiz A, Bozic M. Extracellular Vesicles and Acute Kidney Injury: Potential Therapeutic Avenue for Renal Repair and Regeneration. Int J Mol Sci 2022;23:3792. [PMID: 35409151 DOI: 10.3390/ijms23073792] [Reference Citation Analysis]
7 Gao X, Zhang J, He Z, Chang L, Jian Z, Liu L, Li Y, Hu C, Wei X. Targeting delivery of synergistic dual drugs with elastic PEG-modified multi-functional nanoparticles for hepatocellular carcinoma therapy. International Journal of Pharmaceutics 2022;616:121567. [DOI: 10.1016/j.ijpharm.2022.121567] [Reference Citation Analysis]
8 Chen C, Yaari Z, Apfelbaum E, Grodzinski P, Shamay Y, Heller DA. Merging data curation and machine learning to improve nanomedicines. Adv Drug Deliv Rev 2022;183:114172. [PMID: 35189266 DOI: 10.1016/j.addr.2022.114172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Su C, See DHW, Huang J. Lipid-Based Nanocarriers in Renal RNA Therapy. Biomedicines 2022;10:283. [DOI: 10.3390/biomedicines10020283] [Reference Citation Analysis]
10 Adhipandito CF, Cheung SH, Lin YH, Wu SH. Atypical Renal Clearance of Nanoparticles Larger Than the Kidney Filtration Threshold. Int J Mol Sci 2021;22:11182. [PMID: 34681853 DOI: 10.3390/ijms222011182] [Reference Citation Analysis]
11 Li Y, Wang T, Zhang S, Zhang Y, Yu L, Liu R. Adsorption and electrochemical behavior investigation of methyl blue onto magnetic nickel-magnesium ferrites prepared via the rapid combustion process. Journal of Alloys and Compounds 2021;885:160969. [DOI: 10.1016/j.jallcom.2021.160969] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
12 Gómez-garcía F, Martínez-pulleiro R, Carrera N, Allegue C, Garcia-gonzalez MA. Genetic Kidney Diseases (GKDs) Modeling Using Genome Editing Technologies. Cells 2022;11:1571. [DOI: 10.3390/cells11091571] [Reference Citation Analysis]
13 Mathew AP, Uthaman S, Bae EH, Lee JY, Park IK. Vimentin Targeted Nano-gene Carrier for Treatment of Renal Diseases. J Korean Med Sci 2021;36:e333. [PMID: 34931497 DOI: 10.3346/jkms.2021.36.e333] [Reference Citation Analysis]
14 Liu D, Du Y, Jin FY, Xu XL, Du YZ. Renal Cell-Targeted Drug Delivery Strategy for Acute Kidney Injury and Chronic Kidney Disease: A Mini-Review. Mol Pharm 2021. [PMID: 34337953 DOI: 10.1021/acs.molpharmaceut.1c00511] [Reference Citation Analysis]
15 Ho D. Digital Nanomedicine: A New Frontier for Drug Development. ACS Nano 2022;16:3435-7. [DOI: 10.1021/acsnano.2c01835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]